Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984;1(2):63-71.
doi: 10.1007/BF02934976.

The selection of monoclonal antibodies for tumour localization in patients with colorectal carcinoma

The selection of monoclonal antibodies for tumour localization in patients with colorectal carcinoma

K Sikora et al. Med Oncol Tumor Pharmacother. 1984.

Abstract

We have investigated the ability of various predictive studies to assess which monoclonal antibody (MCA) will be most useful in the immunoscintigraphic localization of metastatic colorectal carcinoma. A set of MCAs was obtained by fusing splenic lymphocytes from rats immunized with membrane preparations from fresh human colorectal cancer. Supernatants from 17 cloned hybridomas were found to bind strongly to colon carcinoma lines by indirect radioimmunoassay. Immunofluorescence using these MCAs on sections of fresh frozen colon carcinoma and normal tissue revealed different staining patterns. Nine MCAs were purified and labelled with 131I. Groups of mice bearing human colorectal tumour xenografts were given radiolabelled MCA and scanned. Six out of the nine MCAs showed tumour localization as determined by rectilinear scanning. Three MCAs which gave good tumour images in mice were selected for clinical evaluation in patients with advanced colorectal cancer. One gave good tumour images, another targeted to bone marrow and the third bound almost exclusively to normal liver. Clinical evaluation is clearly essential in the selection of MCAs for tumour localization.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1980 Aug;40(8 Pt 2):2984-92 - PubMed
    1. Br J Cancer. 1979 Mar;39(3):224-33 - PubMed
    1. Br J Cancer. 1982 Jul;46(1):9-17 - PubMed
    1. Cell. 1976 Sep;9(1):45-55 - PubMed
    1. N Engl J Med. 1980 Jul 3;303(1):5-10 - PubMed

Substances